Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ParaZero Technologies (PRZO) Other Accumulated Expenses (2022 - 2025)

ParaZero Technologies (PRZO) has disclosed Other Accumulated Expenses for 4 consecutive years, with $966612.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 3.49% to $966612.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $966612.0 through Dec 2025, up 3.49% year-over-year, with the annual reading at $966612.0 for FY2025, 3.49% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $966612.0 at ParaZero Technologies, up from $933995.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $966612.0 in Q4 2025, with the low at $690861.0 in Q4 2023.
  • Average Other Accumulated Expenses over 4 years is $841528.8, with a median of $854321.0 recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses decreased 10.82% in 2023, then soared 35.19% in 2024.
  • Over 4 years, Other Accumulated Expenses stood at $774647.0 in 2022, then fell by 10.82% to $690861.0 in 2023, then soared by 35.19% to $933995.0 in 2024, then rose by 3.49% to $966612.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $966612.0, $933995.0, and $690861.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.